ClinicalTrials.gov
public full text
Public Domain
SHAPE:SeeingtheHeartwithAIPoweredEcho
Establish transthoracic echocardiogram (TTE) exams performed with Bay Labs EchoGPS guidance technology can be used in a primary care setting to accurately identify cardiac disease. In Phase I TTE exams with EchoGPS will be compared to findings from a commercially available, FDA 510(k)-cleared reference device (Terason uSmart 3200t, point-of-care ultrasound) without EchoGPS assistance technology. Study is non-significant risk (NSR).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Detection of the Incidence of Pre-existing Cardio-pulmonary Diseases by Using of Echocardiography#840887
- Preoperative Pocket Echocardiography Trial#967959
- Echocardiography in Nursing Home#1186133
- Comparative Evaluation of ChatGPT and Gemini in Approximating Clinically Confirmed Diagnoses From Structured Numerical Pure-Tone Audiogram Data.#385167
- The transthoracic echocardiographic skills of registrars in a department of anaesthesiology#306764
Record · ID 1212484
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive